MSIAN GENOMICS RES CENTRE BHD
KLSE (MYR): MGRC (0155)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.495
Today's Change
+0.015 (3.13%)
Day's Change
0.48 - 0.495
Trading Volume
57,700
Financial
Market Cap
Market Cap
64 Million
NOSH
130 Million
Latest Quarter
Latest Quarter
31-Mar-2023 [#3]
Announcement Date
23-May-2023
Next Quarter
30-Jun-2023
Est. Ann. Date
30-Aug-2023
Est. Ann. Due Date
29-Aug-2023
QoQ | YoY
-132.12% | -245.72%
T4Q Result
Revenue | NP to SH
12,468.000 | 748.000
RPS | P/RPS
9.58 Cent | 5.17
EPS | P/E | EY
0.57 Cent | 86.17 | 1.16%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.29 | 1.71
QoQ | YoY
-86.58% | -32.49%
NP Margin | ROE
2.66% | 1.98%
F.Y. | Ann. Date
31-Mar-2023 | 23-May-2023
Latest Audited Result
Latest Audited Result
30-Jun-2022
Announcement Date
25-Oct-2022
Next Audited Result
30-Jun-2023
Est. Ann. Date
25-Oct-2023
Est. Ann. Due Date
27-Dec-2023
Annual (Unaudited)
Revenue | NP to SH
28,360.000 | 7,211.000
RPS | P/RPS
21.78 Cent | 2.27
EPS | P/E | EY
5.54 Cent | 8.94 | 11.19%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.28 | 1.75
YoY
267.97%
NP Margin | ROE
25.43% | 19.54%
F.Y. | Ann. Date
30-Jun-2022 | 30-Aug-2022
Annualized Result
Revenue | NP to SH
8,180.000 | -4,286.666
RPS | P/RPS
6.28 Cent | 7.88
EPS | P/E | EY
-3.39 Cent | -15.04 | -6.65%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-507.18% | -200.03%
NP Margin | ROE
-59.72% | -11.35%
F.Y. | Ann. Date
31-Mar-2023 | 23-May-2023
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Positive Profit Years | 2 / 4 | 50.00% | 5 / 8 | 62.50% |
| Continuous Quarters Of Positive Profit | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | 0.57% | -1.20% | ||
| Average Net Profit Margin | -117.09% | -51.74% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
| Total Positive Profit Years | 2 / 5 | 40.00% | 5 / 10 | 50.00% |
| Continuous Quarters Of Positive Profit | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Total Dividend Years | 1 / 5 | 20.00% | 1 / 10 | 10.00% |
| Continuous Quarters Of Dividend | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 10 | 0.00% |
| Average ROE | 22.62% | 7.27% | ||
| Average Net Profit Margin | 310.29% | -17.70% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 12,468 | 8,180 | 28,360 | 12,412 | 16,995 |
| NP to SH | 748 | -4,286 | 7,211 | 429 | 2,329 |
| Dividend | 0 | 0 | 0 | 2,277 | 4,554 |
| Adjusted EPS | 0.57 | -3.39 | 5.54 | 0.33 | 1.79 |
| Adjusted DPS | 0.00 | 0.00 | 0.00 | 1.75 | 3.50 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | -58.61% | -86.62% | -72.15% | -78.18% | -84.20% |
| NP to Owner | -132.12% | -245.72% | -200.03% | -1,630.48% | -1,333.62% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | -132.33% | -245.86% | -202.90% | -1,637.29% | -1,336.51% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -56.04% | -26.64% | 0.45% | -71.16% | -51.87% | -34.10% | 1,491.47% | 66.87% | 128.48% |
| NP to Owner | -89.63% | -67.89% | 74.32% | -159.45% | -284.02% | -1,098.99% | 267.97% | 209.56% | 1,580.49% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | -89.71% | -68.14% | 72.97% | -161.21% | -289.50% | -1,128.70% | 267.97% | 209.56% | 1,580.49% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
3 people like this. Showing 50 of 1,464 comments
Kenanga Research starts coverage on MGRC, target price RM1.07
https://www.theedgemarkets.com/article/kenanga-research-starts-coverage-mgrc-target-price-rm107
2022-10-31 11:09
slow slow panjat , minggu lepas hijau , minggu ni hijau , minggu depan hijau , tiap tiap minggu hijau !
2022-11-07 13:43
This counter can out of sudden dropped 0.30 in a day ,happened before and Director said not sure what causes UMA. scary
2022-12-15 16:44
Azri actually just one of director , Mgrc helm by Sasha who is ceo of mgrc
2022-12-19 19:31
No need to be bad mood, you may continue to promote. we all can have a free speech and opinion in i3.
2023-01-05 14:30
Hopefully with the exit of Bintai, this counter can move up, and seems like someone is collecting at 0.74
2023-02-22 12:20
A lot of investors don't trust Azri aka the management because of his age. I am also from the younger generation and believe that the old investors should stop adopting the jaded and traditional mentality that youngsters cannot lead a company in the right direction. A short-term stagflation is upon us so this is a great opportunity for the company to seek the next trend in the healthcare/genomics space
1 month ago
PacBio (PACB) Tops on Q1 Earnings, Raises FY23 Revenue View
The healthcare sector is still doing well, i have no worries.
1 month ago
sell-side traders how many lots do you need to dispose for your client?
1 month ago
keep posting on Linkedin asking people to buy. you think we don't know? no one is gonna be foolish to buy
1 month ago
Go follow Azerai Ahmad on Linkedin and you guys will know what I am talking about. Sell-side traders not enough power to dump on retail investors so the father has to promote the stock
1 month ago
Let put our fingers crossed
As highlighted by public bank security
On 28/4 first resistance at 65 Cts followed by 72.5
4 weeks ago
QR is out. Probably need to wait a few more quarters for its new business to be profitable
2 weeks ago
Post a Comment
Featured Posts
如何利用蜡烛图读懂近期技术走势
Looking for REITs with high returns? Check this out!
[14 MAR-30 JUN] Invite friends to join MQ Trader for extra 1,000 MQ Coins!
Apps
Top Articles
2
3
4
5
Good Articles to Share
6
7
Good Articles to Share
Russian strikes kill three in Odesa, hit Poltava air base - Ukraine
8
Good Articles to Share
Twitter to pay verified creators for ads in replies, Musk says
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
winlast
MGRC reach bottom low aleady, will technical rebound solidly and strongly
2022-08-19 13:45